1. Home
  2. JAGX vs DGLY Comparison

JAGX vs DGLY Comparison

Compare JAGX & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • DGLY
  • Stock Information
  • Founded
  • JAGX 2013
  • DGLY N/A
  • Country
  • JAGX United States
  • DGLY United States
  • Employees
  • JAGX N/A
  • DGLY N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • JAGX Health Care
  • DGLY Technology
  • Exchange
  • JAGX Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • JAGX 3.4M
  • DGLY 3.9M
  • IPO Year
  • JAGX N/A
  • DGLY N/A
  • Fundamental
  • Price
  • JAGX $2.30
  • DGLY $1.99
  • Analyst Decision
  • JAGX Strong Buy
  • DGLY
  • Analyst Count
  • JAGX 1
  • DGLY 0
  • Target Price
  • JAGX $60.00
  • DGLY N/A
  • AVG Volume (30 Days)
  • JAGX 97.0K
  • DGLY 96.3K
  • Earning Date
  • JAGX 08-12-2025
  • DGLY 08-15-2025
  • Dividend Yield
  • JAGX N/A
  • DGLY N/A
  • EPS Growth
  • JAGX N/A
  • DGLY N/A
  • EPS
  • JAGX N/A
  • DGLY N/A
  • Revenue
  • JAGX $11,552,000.00
  • DGLY $18,596,715.00
  • Revenue This Year
  • JAGX $22.41
  • DGLY N/A
  • Revenue Next Year
  • JAGX $30.00
  • DGLY N/A
  • P/E Ratio
  • JAGX N/A
  • DGLY N/A
  • Revenue Growth
  • JAGX 13.93
  • DGLY N/A
  • 52 Week Low
  • JAGX $2.27
  • DGLY $1.93
  • 52 Week High
  • JAGX $110.75
  • DGLY $246.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 28.65
  • DGLY 24.69
  • Support Level
  • JAGX $2.28
  • DGLY $2.07
  • Resistance Level
  • JAGX $2.79
  • DGLY $2.32
  • Average True Range (ATR)
  • JAGX 0.14
  • DGLY 0.11
  • MACD
  • JAGX 0.09
  • DGLY 0.72
  • Stochastic Oscillator
  • JAGX 3.92
  • DGLY 7.32

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: